Farming's Future: Ginkgo and Invaio to Mass-Produce Peptide Pesticides

📊 Key Data
  • The global biopesticides market is valued at over $7 billion in 2026 and is projected to exceed $19 billion by 2030.
  • The European Union's 'Farm to Fork' strategy aims to cut chemical pesticide use by 50%.
  • Ginkgo Bioworks will use its 'Foundry' platform to optimize microbial strains for peptide production at industrial scale.
🎯 Expert Consensus

Experts view this collaboration as a critical step toward sustainable agriculture, offering targeted, environmentally friendly alternatives to conventional pesticides that address rising pest resistance and regulatory pressures.

about 2 months ago
Farming's Future: Ginkgo and Invaio to Mass-Produce Peptide Pesticides

Farming's Future: Ginkgo and Invaio to Mass-Produce Peptide Pesticides

BOSTON, MA – February 18, 2026 – A landmark collaboration announced today between synthetic biology leader Ginkgo Bioworks and agricultural biotech firm Invaio Sciences is set to accelerate a fundamental shift in how farmers protect their crops. The partnership aims to solve one of the most significant hurdles in sustainable agriculture: the mass production of effective, affordable, and environmentally friendly alternatives to conventional chemical pesticides.

By combining Invaio's expertise in discovering potent peptide-based crop solutions with Ginkgo's formidable biomanufacturing platform, the two companies intend to develop commercial-ready microorganisms capable of producing next-generation crop protection at an industrial scale. The collaboration addresses a critical need for growers facing a dual crisis of increasing pest resistance to existing chemicals and mounting consumer and regulatory pressure for more sustainable farming practices.

The Waning Power of Conventional Chemistry

The global agricultural industry is at a crossroads. For decades, synthetic chemical pesticides have been the primary line of defense against pests and diseases, enabling the high yields necessary to feed a growing world population. However, this reliance has come at a cost. The very effectiveness of these chemicals has driven the evolution of resistant pests, forcing farmers into a costly arms race that requires ever-stronger or more frequent applications, often with diminishing returns.

This challenge has fueled a surge of interest in biological alternatives. The global biopesticides market, valued at over $7 billion in 2026, is projected to more than double within the next decade, with some forecasts predicting it will exceed $19 billion by 2030. This rapid growth is driven by a convergence of factors. Stricter regulations, such as the European Union's 'Farm to Fork' strategy which aims to cut chemical pesticide use by 50%, are limiting the toolkit of conventional farmers. Simultaneously, consumer demand for organic and residue-free food continues to climb, creating a powerful market incentive for change. Biopesticides, derived from natural materials, are becoming an essential component of the modern agricultural landscape.

Peptides: Nature’s Precision-Guided Munitions

At the heart of the Ginkgo-Invaio collaboration are peptides—small proteins that represent a new frontier in crop protection. Unlike broad-spectrum chemicals that can harm beneficial insects like pollinators, many peptides function with surgical precision. These molecules, often inspired by natural sources like spider venom, can be designed to target specific neural receptors found only in target pests, leaving bees, ladybugs, and other helpful species unharmed.

This high specificity not only makes them safer for the environment but also provides a powerful new tool against resistance. By introducing novel modes of action, peptides can be effective against pests that have evolved defenses against entire classes of chemical insecticides. Invaio Sciences, a company spun out of the life sciences venture firm Flagship Pioneering, has built its platform on discovering and developing these highly targeted solutions.

"Ginkgo's technology offers us a clear path to manufacturing our peptides at scale," said Amy O'Shea, CEO of Invaio Sciences, in a statement. "We are excited to partner with Ginkgo to develop much-needed next generation crop protection solutions for persistent pests and diseases."

Historically, the commercial viability of such biologicals has been hampered by two main factors: bioavailability and manufacturing cost. Invaio is tackling the first challenge with innovative delivery systems, including precision injectors that deliver active ingredients directly into a plant's vascular system. The second, and arguably larger, challenge of cost-effective, large-scale production is where Ginkgo Bioworks enters the picture.

From Lab Discovery to Industrial Reality

Ginkgo Bioworks operates what it calls 'the Foundry,' a highly automated platform that uses robotics and proprietary software to engineer biology at an unprecedented speed and scale. For this collaboration, Ginkgo will deploy its full suite of tools, including its autonomous Reconfigurable Automation Carts (RACs) and Catalyst automation software, to optimize microbial strains for protein production.

The goal is to engineer a microorganism—likely a yeast or bacterium—that acts as a microscopic factory, churning out Invaio's complex peptides through industrial fermentation. By iteratively designing, building, and testing thousands of biological variations, Ginkgo can dramatically increase the yield and efficiency of the manufacturing process, driving down costs to a level that makes the final product competitive with conventional chemicals.

"At Ginkgo, we understand the urgency for next-generation agricultural solutions that can support growers, consumers and the planet," stated Jill Bradshaw, General Manager of Ginkgo's Microbial Solutions business unit. "We are excited to work alongside our partners at Invaio to deliver a manufacturing strain and process that allows them to continue to focus on the discovery of next-generation biological solutions important to crop protection."

This partnership model—where a discovery-focused company like Invaio outsources the complex task of biomanufacturing scale-up to a specialized platform like Ginkgo—is becoming increasingly common in the biotech industry, as it allows each partner to focus on their core strengths and accelerate the path from a laboratory breakthrough to a marketable product.

A New Toolkit for the Modern Farmer

For the collaboration to be truly successful, the final product must deliver on the promise of being 'grower-friendly.' This term encompasses more than just the sticker price. It represents a holistic value proposition for the farmer, balancing cost with efficacy, ease of use, and overall return on investment.

By offering a potent new weapon against resistant pests, peptide solutions can help farmers protect yields that would otherwise be lost. Furthermore, Invaio's precision delivery methods promise to reduce waste, ensuring the active ingredient goes exactly where it's needed. This efficiency could mean farmers use significantly less product compared to traditional broad-acre spraying, saving on both input and labor costs. The stability of these molecules, which can be engineered to withstand field conditions without requiring a costly cold supply chain, further simplifies logistics for the grower.

Ultimately, this collaboration is not just about replacing one product with another; it's about providing farmers with a more resilient and sustainable toolkit. By integrating highly effective, nature-positive solutions into their existing practices, growers can improve farm profitability, meet the growing demand for sustainably produced food, and contribute to a healthier ecosystem, securing the future of agriculture for generations to come.

Sector: AI & Machine Learning Software & SaaS
Theme: Decarbonization ESG Generative AI Machine Learning Automation
Product: ChatGPT
Metric: EBITDA Revenue
Event: Acquisition
UAID: 16791